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May 2021 
 
 Approximately 34.2 million U.S. adults were diagnosed with type 2 diabetes in 2018 and 
diabetes prevalence is projected to reach 60.6 million by 2060. A predicted 88 million adults 
have prediabetes, but only 15.3% have been diagnosed by a medical provider. Approximately 
15-30% of the population with prediabetes will develop diabetes within 5 years without lifestyle 
modification to decrease risk. Reduced incidence of diabetes is an urgent priority for Healthy 
People 2030 and increased participation in lifestyle change programs is a primary objective. The 
Diabetes Prevention Program promotes behavior modification to prevent or delay diabetes. 
Despite evidence to support effective intervention, many individuals with prediabetes do not 
engage in behavior modification to lower their risk; therefore, it is critical to understand the 
factors that influence individual motivation to engage in risk reduction behaviors. A prediabetes 
diagnosis based on a clinical blood test or self-risk assessment is required for enrollment in the 
program and thus, the purpose of this study is to examine whether participants who completed 
the program have different outcomes based on their mode of diagnosis of prediabetes.  
This research used archival data from participants (N =793) in Diabetes Prevention 
Programming, 46.7% (n = 370) reported clinical testing and 53.3% (n = 423) completed a self-





conducted to explore the association between mode of diagnosis—clinical blood test or self-risk 
assessment on outcomes of attendance, physical activity, and weight loss in a diabetes prevention 
program. Results for the measures of attendance, physical activity, and measures of goal 
completion outcomes indicate significant results that reject the null hypothesis that there is no 
difference in outcomes between the two sample groups. The study measures for percentage of 
weight loss were not significant and failed to reject the null hypothesis. Increased understanding 
of the mechanisms by which diagnosis method may impact outcomes could be used to inform 
screening procedures and policies as well as communication strategies for participation. The 
results may influence physician attitudes regarding patient self-assessment and provide new 
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Problem Statement  
 Diabetes mellitus, referred to as type 2 diabetes or diabetes, is a commonly known, 
irreversible, chronic disease approaching epidemic proportions in the United States (U.S.). 
Approximately 34.2 million adults in the U.S. were diagnosed with type 2 diabetes as of 2018 
and an additional 7.3 million people have it but have not been diagnosed by a medical 
professional (Centers for Disease Control and Prevention [CDC], 2020a, 2020b). Adverse health 
conditions of diabetes are the result of excess blood glucose that damages blood vessels and 
severely increases risk for morbidities like stroke, cardiovascular disease, and renal (kidney) 
disease, as well as nerve, tissue, and eye damage. A medical status known as prediabetes 
proceeds the development of diabetes; it is a serious (but reversible) health condition that 
indicates a high risk for developing diabetes. Approximately 88 million—or 1 in 3—adults in the 
U.S. have this condition, but only a small amount (15.3%) report that a health professional told 
them that they have prediabetes and may be at risk (CDC, 2020a, 2020c). Approximately 15-
30% of the population with prediabetes will develop type 2 diabetes within 5 years if they do not 
engage in lifestyle modification or interventions to decrease their risk. Behavior modification to 
prevent diabetes can improve health, reduce the incidence of diabetes and its associated 
complications, and save substantial medical costs (Institute for Clinical and Economic Review 
[ICER], 2016). 
 Despite general awareness of the health threat associated with diabetes and evidence to 
support effective intervention at the prediabetes stage, many individuals with prediabetes do not 





2009). To minimize incidence and prevalence of type 2 diabetes in the U.S., it is critical to 
understand the factors that influence individual motivation to engage in risk reduction behaviors.  
Background 
 Diabetes is a disease caused by elevated blood glucose levels and type 2 diabetes is the 
most common subtype. There is an increased risk of chronic health conditions, disease, and 
disability for people with diabetes and they die an average of 4.6 years earlier than people who 
are non-diabetic (Bardenheier et al., 2016; CDC, 2020a). Diabetes was the seventh leading cause 
of death in the U.S. in 2017 (CDC, 2020b). The direct and indirect costs associated with diabetes 
care in 2017 were approximately $327 billion and individuals with diagnosed diabetes have 
average medical cost up to 2.3 times higher than non-diabetic patients (American Diabetes 
Association [ADA], 2018; CDC, 2018a). 
Diabetes Prevalence 
 Although 34.2 million adults in the U.S. were diagnosed with diabetes in 2018, an 
estimated 7.3 million people are undiagnosed, and 1 in 6 adults will develop diabetes by the year 
2060 (CDC, 2020a, 2020c; Lin et al., 2018). Reduction of diabetes cases is an urgent priority for 
Healthy People 2030 (HP2030) and increased participation in lifestyle change programs is a key 
objective to lessen diabetes incidence (Healthy People [HP], 2020). Reduction of the incidence 
rate could lower the diabetes prevalence by 5 million within 10 years (Lin et al., 2018). 
Prediabetes  
  Prior to developing diabetes, individuals have prediabetes, which is defined as a 
condition where blood glucose levels are elevated more than normal and the higher level can be 
detected through clinical testing. Individuals who are overweight, have a sedentary lifestyle, and 





gestational diabetes and some racial and ethnic identities. Approximately 88 million U.S. adults 
over 18 had prediabetes in 2018, but only a small portion (15.3%) received a clinical diagnosis 
from a medical professional regarding their condition (CDC, 2020c). A person’s increased risk 
for prediabetes may be identified by either a self-risk assessment test or by a clinical diagnosis 
determined by a medical professional based on results from blood glucose tests. Health care 
professionals and health organizations use different methods to identify, diagnose, and treat 
prediabetes. Health care providers may choose to monitor patient glucose levels over time rather 
than recommend a lifestyle modification program for diabetes prevention. Most individuals with 
prediabetes will eventually develop diabetes—some within 5 years—if they do not engage in 
lifestyle modification or interventions to decrease their risk (ICER, 2016; Tuso, 2014).  
National Diabetes Prevention Program 
 Clinical trials have determined that weight loss and increased physical activity are 
effective ways to reduce risk for diabetes (Ely et al, 2017; Knowler et al., 2002). The Diabetes 
Prevention Program (DDP) is a one-year behavior modification class that has been successful in 
helping individuals prevent or delay diabetes (Knowler et al., 2002). Participants qualify for the 
program with either a clinical blood test of prediabetes or by completing an evidence-based 
diabetes risk assessment. Certified lifestyle coaches facilitate the DPP in weekly group sessions 
using a theory-based curriculum that supports positive lifestyle change through group interaction, 
skill-building, positive affirmation, and goal setting. Less than half of the participants who 
register for DPP complete the program and attrition is highest after the first session, which could 







The Use of Theory in Behavior Change 
 Health behavior theories identify factors that influence a person’s behavior and provide a 
framework for intervention and health improvement. The Social Cogitative Theory (Bandura, 
1986) is based on a model of environmental factors, individual behavior, and personal factors 
that intersect to influence individual health-related behaviors. This framework was used to 
develop the DPP curriculum and the session topics, interactive learning opportunities, and 
personal goal setting activities all serve to influence positive health behavior change. Theories 
such as the Transtheoretical Model of Change, Health Belief Model, Theory of Reasoned Action, 
and Theory of Planned Behavior are used to identify and explain specific factors that may 
influence a person to move towards adoption of new behavior. Once a person engages in 
behavior change, these factors may also influence their ability to successfully achieve the 
expected outcome(s) from the new behavior. Therefore, examination and application of theory 
constructs can be used to consider whether the method of diagnosis for prediabetes may 
influence participant outcomes due to behavior change in a DPP.  
Implications for Research 
 The implications for this research are multifaceted and varied, regardless of whether the 
diagnosis method demonstrates a salient factor in participant outcomes from the prevention 
program. The upward trend of diabetes incidence and prevalence continues to drive healthcare 
needs and associated costs towards tertiary treatment of diabetes and related complications. If 
healthcare expenses and overhead are focused on disease management, it may jeopardize the 
organizational ability to promote and sustain effective prevention programming. An association 
between mode of prediabetes diagnosis and DPP outcomes could further inform the use of health 





understanding of the mechanisms by which diagnosis method may impact DPP outcomes may be 
used to inform screening procedures and policies as well as recruitment and retention 
communication. Thus, the research aim of this study is to explore the association between mode 
of prediabetes diagnosis— clinical blood test or self-risk assessment— on measured DPP 
outcomes of attendance, physical activity minutes, and percentage of weight loss. A theoretical 






LITERATURE REVIEW  
Diabetes in the United States 
 The purpose of this section is to illustrate the magnitude of diabetes as a major health 
concern and provide background information to support the importance of intervention tactics to 
reduce the incidence of disease. Diabetes is a metabolic disease related to elevated blood glucose 
levels. Increased blood glucose is the result of either defective insulin secretion (type 1 diabetes), 
or ability to effectively use insulin in the body (type 2 diabetes). Gestational diabetes (GMD) 
occurs when pregnancy hormones inhibit effective insulin use, resulting in insulin resistance and 
elevated blood glucose. Type 2 diabetes (indicted hereafter as diabetes) is the most common 
subtype of diabetes, accounting for approximately 90-95% of all diagnosed cases of adult 
diabetes (CDC, 2020a, 2020b, 2020c; Sapra & Bhandari, 2020).  
Diabetes Impact on Health 
 When the body does not process excess glucose effectively, blood sugar levels increase, 
damage blood vessels, and may severely increase risk for developing life-threatening morbidities 
(ADA, 2020a). People with diabetes often develop additional risk factors for disease like above 
normal cholesterol, triglycerides, and/or blood pressure levels. Evidence shows that diabetes has 
been linked to an increased risk of developing stroke, heart disease, or kidney failure, and 
outcomes of blindness, amputations of lower extremities, development of dementia and 
Alzheimer’s disease, and increased risk for disability and premature death (CDC, 2020a; Dolan 
et al., 2018; Giovannucci et al., 2010). Disability may develop up to 7 years earlier in adults with 
diabetes and as a result, experience more years in a disabled state than those without diabetes. 





remaining life disabled and report similar associations for women. An additional 1 to 2 years 
spent in a disabled state may severely impact quality of life for people with diabetes (CDC, 
2020a, 2020c; Bardenheier et al., 2016). In 2017, over 83,500 death certificates indicated 
diabetes as the cause of death in the U.S., making it the seventh leading cause of death (crude 
rate 25.7 per 100,000). Over 270,702 death certificates listed diabetes as contributing to or 
underlying the cause of death (CDC, 2020b). Individuals with diabetes die 4.6 years earlier and 
have 60% higher risk of premature death than people who are non-diabetic (Bardenheier et al., 
2016). 
Financial Impact of Diabetes 
  The American Diabetes Association (ADA) states that diabetes is a substantial economic 
burden on society. In the U.S., approximately $327 billion was spent on direct ($237) and 
indirect ($90) costs related to diagnosed diabetes in 2017; this was an increase of 26% in 
economic costs over the prior 5 years (ADA, 2018). Excess medical costs associated with 
diabetes increased between 2012 and 2017 from $8,417 to $9,601 per person. Indirect costs are 
not associated with the direct treatment of disease but they have a financial effect on society. 
Diabetes-related indirect costs include work absenteeism, less productivity due to disability or 
health conditions, and premature mortality. Direct medical costs include the increased cost of 
medical care that persons with diabetes often incur. People with diagnosed diabetes have average 
medical care costs of $16,750 annually, with $9,600 attributed to direct medical costs of 
diabetes. The increased average medical cost may be up to 2.3 times higher than non-diabetic 
patients due to health conditions related to diabetes and increased need for hospital services 







 Over 34.2 million adults in the U.S. in 2018 were diagnosed with diabetes and an 
estimated 7.3 million more were undiagnosed. The number of diagnosed persons is projected to 
reach 60.6 million (>1 in 6 adults) by 2060 (CDC, 2020a, 2020c; Lin et al., 2018). Prevalence of 
diabetes increased steadily from 1999 through 2016 for both men and women as well as all age 
groups, education levels, and racial and ethnic groups. A portion of the projected prevalence 
rates is assumed due to improvements in health care and diabetes self-management or lifestyle 
changes that result in people living longer with diabetes. Despite a decrease in the incidence rate 
for adults in the past ten years, there has been an upward trend in the rate among adolescents and 
children, as well as increased complications related to diabetes in younger adults aged 18-44 
(CDC, 2020a, 2020b, 2020c; Lin et al., 2018). Slowing the incidence of diabetes has become an 
urgent priority. A reduction in the number of diagnosed diabetes cases each year is one of the 
Leading Health Indicator (LHIs) for health improvement and wellbeing by Healthy People 2030 
(HP2030). The LHI goal is 5.6 new cases of diabetes per 1,000 adults aged 18 to 84 years; a 
reduction of 1 new case per 1,000 over cases reported in 2016-2018. One objective to achieve 
this goal is increased participation in lifestyle change programs (Healthy People, 2020). Analysis 
predicts a 20% reduction in the incidence rate of diabetes will reduce the diabetes prevalence by 
5 million in 2030, and 10 million in 2060 (Lin et al., 2018). 
Contributing Factors for Diabetes 
 Many of the risk factors for diabetes-related complications are behavior-related outcomes 
that may have contributed to development of the disease. Physical inactivity and smoking are 
common factors for hypertension, increased cholesterol measures, and overweight/obesity (CDC, 





fatigue, blurred vision, frequent urination, or increased hunger and thirst. People who develop 
diabetes go through a prediabetes status where rising blood glucose levels indicate an increase in 
risk before development of the disease. Because there is no known cure, and medical treatment 
cannot prevent most of the health complications that are associated with it, prevention is the 
preferred medical action for diabetes. Medical professionals have an opportunity to help patients 
achieve diabetes prevention if they intervene at the prediabetes stage (Tuso, 2014). This 
opportunity for intervention may be complicated by a lack of standard protocol and procedures 
for routine screening and perceptions of services available for prevention. 
Prediabetes Status  
 This section describes the physical state that precedes onset of diabetes and explains how 
the pre-disease state provides opportunity to lower risk of diabetes. Prediabetes is a reversible 
medical status where blood glucose levels are higher than what is considered normal, but not 
high enough to be classified as diabetes. Several tests are used to determine whether a person’s 
blood glucose is above normal levels. A fasting plasma glucose (FPG) test measures blood sugar 
after fasting overnight and a level of 100 to 125 mg/dL indicates prediabetes in the U.S. The oral 
glucose tolerance test (OGTT) is also conducted after an overnight fast, and measures a person’s 
blood sugar before and after consumption of liquid glucose. Blood levels are checked at 1 and 2 
hours, and prediabetes is determined if the levels are 140 to 200 mg/dL. The Hemoglobin A1c 
(A1c) test measures glucose levels in blood cells over time, usually 90 days; a score between 5.7-
6.4% indicates prediabetes. Approximately 50.0% of women with GDM eventually develop 








 In 2018, approximately 88 million (34.5%) of U.S. adults aged 18 years or older had 
prediabetes, but only 15.3% were aware of their condition through a clinical diagnosis from a 
health professional (CDC, 2020c). Approximately 35 million adults with prediabetes are 45 to 64 
years of age and 24 million are 65 years and older; however, the prevalence of prediabetes in 
young adults and adolescents in the U.S. has increased (CDC, 2020a). A 2005–2016 study found 
that 1 in 5 adolescents (18.0%) and 1 in 4 young adults (24.0%) had been diagnosed with 
prediabetes (Andes et al., 2019). Prevalence of prediabetes was similar among all racial/ethnic 
groups and education levels; however, a higher percentage of men (37.4%) than women (29.2%) 
had prediabetes based on age-adjusted data for U.S. adults aged 18 years or older 2013–2016 
(CDC, 2020b). An estimated 15-30% of individuals with prediabetes will develop diabetes 
within 5 years, and up to 70% of individuals with prediabetes will eventually have diabetes if 
they do not engage in lifestyle modification or interventions to decrease risk (Institute for 
Clinical and Economic Review [ICER], 2016; Tuso, 2014).  
Prediabetes Impact on Health 
 The measure of risk for developing diabetes is closely associated with an individual’s 
A1c or FPG levels when they are diagnosed. If patient levels are in the higher range, with A1c 
near 6.4%, and FPG near 125 mg/dl, they are more likely to develop diabetes. A1c numbers 
closer to 5.7% and FPG numbers closer to 100 mg/dl are more likely to maintain or lower their 
glucose levels to a normal range although this likelihood may be impacted by the patient’s level 






In addition to increasing the risk of developing diabetes, evidence suggests that higher 
than normal blood glucose levels may result in above normal cholesterol, triglycerides, and/or 
blood pressure levels as well as kidney and nerve damage at the prediabetes stage (CDC, 2020a; 
Tabák et al., 2012). 
Contributing Factors for Prediabetes 
 Family history, genetics, and a combination of lifestyle factors (food choices, sedentary 
lifestyle, stress levels, and sleep disturbances) may contribute to development of prediabetes, yet 
it is often simply the result of being overweight or obese. The prevalence of prediabetes for 
individuals with normal weight is 28%, and it increases to 36% for overweight, and 40% for 
those considered obese. Overweight/obese is a contributing factor for insulin resistance, but not 
all overweight individuals develop prediabetes or diabetes, and there are a minority of 
individuals with prediabetes who are not overweight (The diaTribe Foundation, n.d.). The 
ADA/CDC Prediabetes Risk Test (Figure 1) is used to indicate a likelihood of prediabetes status 
based on answers to questions related to risk factors for diabetes. The assessment surveys 
whether the individual is 45 years or older, overweight, physically active less than 3 times a 
week, and asks if they have a family member (parent or sibling) with diabetes. Women are asked 
to indicate if they had gestational diabetes, or gave birth to an infant weighing 9 pounds or more. 
Racial and ethnic identity demographics are also considered as African Americans, Hispanics, 
American Indians, and some Pacific Islanders and Asian Americans experience higher risk for 
diabetes than Caucasian identity. Individuals with scores that indicate increased risk are 
encouraged to talk to a medical provider to see if additional testing is needed to determine 






Clinical Diagnosis and Referral for Prediabetes 
 The information in this section is to expand on the role of health professionals in the 
diagnosis of patient diabetes risk and offer insight regarding barriers to intervention and 
prevention tactics. The clinical definition of prediabetes is a source of controversy and varies 
among health care professionals and health organizations. The World Health Organization 
(WHO) defines prediabetes with the criteria of an FPG of 110-125 as well as an oral glucose 
tolerance test (OGTT) of 140 to 200 mg/dL. The ADA criteria are the same for OGTT, but the 
FPG test has a lower value of 100-125 mg/dL to define prediabetes. In addition, the U.S. criteria 
use an A1c measure of 5.7% to 6.4% to indicate prediabetes (ADA,2020c; Barry et al, 2018). 
Clinical diagnosis of prediabetes in the U.S. usually starts with the FPG, then progresses to an 
OGTT test to confirm results. An A1C test may be preferred by providers because it does not 
require fasting or extended lab visits. A1c test ideally represents a person’s average glucose level 
over 90 days, rather than a single point in time like the FPG and OGTT. However, certain 
genetic traits, separate from blood glucose, are known to substantially impact A1c levels and 
may make this an inaccurate measure for the total population (Bansal, 2015).  
Potential to Impact Patient Health 
 Assessment of knowledge regarding prediabetes screening standards among primary care 
providers (PCP) revealed that only 6% were able to correctly identify the risk factors that 
indicate a need for screening for prediabetes and only 17% knew the fasting glucose and A1c 
laboratory parameters used for diagnosing prediabetes (Tseng et al., 2017). The survey 
participant responses indicated gaps in their knowledge related to ADA recommendations for 
lifestyle modifications to decrease risk of diabetes. Professional organizations that provide 





in their lack of knowledge (Tseng et al., 2017). Results of a survey of self-reported prediabetes 
screening, testing, and referral among 1256 PCP’s indicated that 97% of the providers tested for 
prediabetes with one of the ADA recommended blood glucose tests. One-third (27%) of the 
providers used the ADA/CDC Prediabetes Risk Test (Figure 1) and only 23% referred their 
patients to attend CDC-recognized LSM classes (Nhim et al., 2018). These results are consistent 
with the findings in a survey of family physicians (n 1248) to measure attitudes towards 
prediabetes and screening. Most physicians used blood glucose as their screening method for 
prediabetes (Mainous et al., 2016). A little more than half (52.4%) indicated that they followed 
the national guidelines for diagnosis, and one-third reported uncertainty regarding whether their 
patient care and screening was consistent with recommended guidelines.  
Factors That Influence Prediabetes Screening and Intervention 
 The survey of family physicians (2016) revealed that physicians often perceived barriers 
to prediabetes treatment on their patient’s behalf, including economic challenges (71.9%), ability 
to sustain motivation (83.2%), and the patient’s ability to modify their lifestyle (75.3%). 
Seventy-five percent of those surveyed indicated that adequate time to educate patients regarding 
diabetes was a barrier to prevention methods (Mainous et al., 2016).  
Analyses of 2016-2017 National Health Interview Survey (NHIS) data of adults with 
diagnosed prediabetes revealed 73.5% (95% CI, 71.6.5%-75.3%) reported their medical provider 
gave them advice or referral for behavior modification after their clinical diagnosis of 
prediabetes; however, only 35% (95% CI, 30.5%-39.8%) reported engagement in the 
recommended modification within a year of their diagnosis (Ali et al., 2019). Adults with risk 
factors of higher-than-normal BMI and ADA/CDC risk scores, but without a clinical diagnosis of 





or referral from their medical provider and only 33.5% (95% CI, 30.5%-39.8%) reported 
engagement in the recommended modification within a year of receiving the advice.  
 Participation in LSM programs to prevent diabetes was low for both groups; only 4.9% 
(95% CI, 4.1%-6%) of those diagnosed with prediabetes and less than 1% (0.4%; 95% CI, 0.3%-
0.5%) of adults at risk received referral or advice to engage in LSM program for diabetes 
prevention (Ali et al., 2019; Venkataramani, et al., 2018). Health care professionals gave general 
physical activity or dietary recommendations 2 to 3 times more often than they referred patients 
to formal behavior modification programs (Ali et al., 2019).  
National Diabetes Prevention Program  
 This section introduces the specifics of the nationally funded program developed in 
response to the rising incidence of diabetes in the United States. The origin of the NDPP is a 
randomized, clinical trial sponsored by the National Institute of Diabetes and Digestive and 
Kidney Diseases (NIDDK). The research aim was to determine if certain interventions could 
prevent or delay diabetes in adults with blood glucose levels that were higher than normal, but 
not diagnosed as having diabetes (Knowler et al., 2002). Research confirmed that minimal 
weight reductions of 5%-7% achieved through lifestyle modification, dietary changes, and 
increased physical activity of at least 150 minutes per week were effective in 58% (95% CI 48-
66) reduction of incidence of diabetes (Ely et al, 2017; Knowler et al., 2002).  
The Diabetes Prevention Program Outcomes Study (DPPOS) analyzed whether the 
results of the DPP trial would result in long-term diabetes risk reduction. Eighty-eight percent of 
the (surviving) individuals from the 1996-2001 DPP trial enrolled in the ten-year follow-up 
outcome study. Results of the DPPOS study showed that modest weight loss resulting from 





and 49% in those over age 60 (National Association of Chronic Disease Directors [NACDD], 
n.d.; National Institute of Diabetes and Digestive and Kidney Diseases [NIDDK], 2002).   
National Diabetes Prevention Program Impact on Health 
 The U.S. Congress authorized the CDC to develop NDDP infrastructure to support 
evidence-based, cost-effective intervention programs as a public/private partnership with 
qualified organizations in the U.S. (CDC, 2020e). In 2012, six national organizations— 
including the YMCA of the U.S.— received funding to implement the DPP across multiple states 
over a 4-year timeframe. The goal was to test whether the prevention program offered in a group 
setting would result in long-term diabetes risk reduction in a community setting. Nearly 15,000 
participants were enrolled in the 165 sites established during the four years and program data 
was used to create best practice models for program delivery that are used today (Nhim et al., 
2019).  
 In 2016, the Centers for Medicare and Medicaid Services (CMS) approved the national 
DPP program as a cost-saving, patient care improvement model. It then received certification as 
a preventative service model for expansion by The Department of Health and Human Services 
(HHS) and the Medicare Diabetes Prevention Program (MDPP) was made available to 
beneficiaries in 2018. As of December 2019, 185 organizations had enrolled as MDPP suppliers 
for program delivery in 760 locations, and 11 states had elected to include the NDPP as a health 
benefit for Medicaid beneficiaries (CDC, 2020a). These critical policy expansions were a step 
towards reducing diabetes incidence in the estimated 46.6% of seniors with prediabetes, as well 







Diabetes Prevention Programming Delivery 
 To ensure fidelity of evidence collected from program delivery organizations, the CDC 
also established the Diabetes Prevention Recognition Program (DPRP) (CDC, 2019). To achieve 
recognition, organizations must use the NDDP curriculum (or approved adaptation) and ensure 
lifestyle coaches are trained in facilitation to support the theoretical concepts. Because the 
program was developed for persons known to be at risk for developing diabetes, a minimum of 
35% of participants in a year-long program must be eligible for enrollment based on a clinical 
blood test determining prediabetes or a history of GDM. The remaining participants (65% 
maximum) must be eligible based on the ADA/CDC Prediabetes Risk Test (Figure 1) (CDC, 
2018b; Ely et al., 2017). Recognized programs are required to submit annual data on participant 
attendance, weight, and duration of physical activity in minutes, which are used by CDC to 
assess program impact on preventing or delaying the onset of diabetes (CDC, 2019; ICER, 
2016).  According to the national registry of CDC-recognized diabetes prevention programs, 
there are approximately 1800 CDC-approved LSM programs in the U.S. (CDC, 2020f).  
Yakima County Diabetes Prevention Programs 
 Washington State has over 50 CDC-recognized program locations (CDC, 2020f). Three 
programs—Yakama Indian Health Service, Yakama Nation Wak’ishwi Program, and Virginia 
Mason Memorial (VMM)—are located in Yakima County; the geographical location of this 
study (CDC, 2020f). Yakima Valley Memorial Hospital, a rural nonprofit hospital system 
(operating as VMM during the study period), implemented English and Spanish diabetes 
prevention programming in 2013 in partnership with YMCA of Yakima as part of the national 





program received official recognition status in 2017 and has provided LSM programming to 
approximately 1400 participants through 2020.  
 DPP has been widely promoted within the Central Washington region through paid 
advertisement, direct mail, social media, news coverage, and patient education materials 
distributed at medical and health clinics. Community health educators meet frequently with 
providers associated with VMM to distribute program materials, share data outcomes, and 
streamline the process for patient referral to the program. VMM also participates in many 
community health and wellness events in Yakima County, offering fasting blood glucose 
screening and consultation along with education for health improvement that may include 
referral to DPP (VMM, 2020).   
The VMM program requires attendance at a community orientation meeting or 1:1 
counsel with the program coordinator before enrollment in DPP. Orientation attendees receive 
diabetes prevention educational materials, view or hear testimonials from former participants, 
and those without a clinical diagnosis of prediabetes are encouraged to complete the ADA/CDC 
Prediabetes Screening Test (Figure 1) to determine their risk of developing diabetes. VMM 
estimates that 99% of attendees who attend the orientation enroll in the program within two 
months (VMM, 2020).  
 Elements of Diabetes Prevention Programming 
  The requirements for enrollment in DPP include adult 18+, overweight, BMI ≥ 24 (≥ 22, 
if Asian), non-pregnant, and have not been diagnosed with type 1 or type 2 diabetes. Participants 
must have a diagnosis of prediabetes based on a clinical blood test, a previous diagnosis of 





program covered by Medicare must have had a recent clinical blood test indicating prediabetes 
(CDC, 2020e).  
The DPP curriculum is delivered by certified lifestyle coach/facilitators in a group 
environment of approximately 18 to 20 people. The structure of the 1-year program consists of 
16 weekly 1-hour core sessions, 2 bi-monthly post-core sessions, then 4 monthly post-core 
sessions. Facilitators weigh and record the participant weight measures before each session and 
collect participant-reported measures of physical activity minutes starting in week 6. Participants 
are encouraged to attend every session and track their progress towards the program outcome 
goals of 5%-7% weight loss and 150 physical activity minutes per week (CDC, 2020e). 
 The curriculum used in the original clinical trial was developed and written at the 
University of Pittsburgh by the DPP Lifestyle Resource Core (University of Pittsburg, 2021). 
The Diabetes Training and Technical Assistance Center was established in 2009, at Emory 
University’s Rollins School of Public Health to adapt the curriculum for delivery in a group 
format and create a training certification program for lifestyle coaches (Emory University, 2020). 
The lifestyle change curriculum is based on the Social Cognitive Theory (SCT) developed by 
Bandura (1986), who theorized a reciprocal relationship and determinism between a person’s 
behavior, cognitive thoughts and abilities, and their environment. Six major constructs influence 
behavior within the SCT; outcome expectations and expectancies, behavioral capability, self-
efficacy, the environment, and the perceived behavior of others (Bartholomew et al., 2020; 
DiClemente et al., 2013; Rimer, et al., 2005). Lifestyle coaches are certified in curriculum 
delivery that reinforces the SCT constructs and they support participants with weekly feedback 
to guide healthy eating decisions while forming new health behavior habits. Participants learn 





participate in group sharing and knowledge interaction, and set outcome goals based on their 
individual health needs. As participants achieve their goals, they build confidence in their ability 
to change behavior and model that behavior within their group and social environment. The 
group format and interactive learning environment encourage ongoing program attendance which 
is considered a best practice for attaining the goal outcome goals for the program. (Baker et al., 
2011; CDC, 2018b; 2018c).  
Diabetes Prevention Program Results 
 Participants who attend more than 17 DPP sessions and report >150 minutes of physical 
activity per week show median weight-loss rates of 6%, and weight loss of 0.31% (p <0.0001) 
for every additional session attended, as well as an additional 0.3% (p <0.0001) for every 30 
minutes of physical activity reported by participants per week (Ely et al., 2017). Alva (2019) 
measured attendance among Medicare beneficiaries enrolled in DPP and compared the findings 
with claims data to determine the impact of attendance on weight loss and medical costs. The 
mean attendance was 14 (SD 6 sessions, 24 max), participants lost an average of .72 lbs. (.67 - 
.77 lbs.) per week, and saved approximately $58 (mean) in medical cost for each session they 
attended. Completion of at least 14 sessions is recommended to achieve a weight loss of 5% and 
obtain relevant medical cost savings (Alva, 2019).    
Evidence shows increased positive outcomes associated with how long the individual is 
in the program and significant association with participation beyond the 16 core weekly sessions 
and achievement of >5% weight loss (Ely et al., 2017; Jeffers et al., 2019). However, less than 
half of the participants (43%) who register for DPP complete the 16-week core curriculum.  
Attrition is highest after the first session, which could be attributed to behavior constructs such as 





expectations of the program, or their motivation and attitude toward behavior change (Cannon et 
al., 2020; Ely et al., 2017). 
 Health behavior theory is used to understand how constructs such as expectations, 
behavioral capability, and self-efficacy (among others) influence engagement and retention in 
DPP as well as behaviors prior to participation in health improvement strategies. They can 
provide insight regarding the factors that may influence an individual who has been diagnosed 
with prediabetes or has completed a self-test to determine their diabetes risk, to move towards 
participation in prevention opportunities.  
Theoretical Frameworks to Influence Behavior Change and Program Outcomes 
 The purpose of this section is to describe some of the ways that individuals may move 
towards behavior change and illustrate how health improvement programs may benefit from 
using application of theory to understand those behaviors. The theoretical frameworks featured 
in this section will be applied to understand the ways that the method of diagnosis—clinical test 
or self-risk assessment—may influence outcomes attained through a lifestyle management 
program such as DPP. 
 In order to complete this analysis and application of theory, some assumptions have been 
determined that generalize the knowledge, experience, and expectations of individuals prior to 
their participation in DPP. (Enrollment in the program requires either a clinical diagnosis of 
prediabetes or a self-risk assessment that confirms a person’s risk of developing diabetes.) If a 
person has received a clinical diagnosis of prediabetes it could be presumed that they were 
unaware of their condition prior to diagnosis and their initial perception would be influenced by 
the attitude, perceptions, and knowledge of the provider as it relates to diabetes risk and DPP as a 





information rather than actively seeking a diagnosis. It is the expectation that the individual has a 
professional relationship with their provider and that they will have contact with the provider 
during or after they participate in the program.  
 The self-risk assessment has been extensively promoted through health improvement 
outreach at a national and local level and was also provided at monthly orientation sessions 
hosted by the DPP coordinator. If an individual completes a risk test as a prerequisite to 
participation in DPP, it could be presumed that they were aware of the prevention program and 
have a perception of the value of participation in the program. It could also be assumed that they 
are in a state of seeking information. If they completed the test after attending orientation, it 
could be assumed that it was their decision to attend the orientation, perhaps with the intention to 
enroll, before receiving information about the program. It can be expected that the individual 
used critical thinking and honest assessment when they completed the risk test and in a state of 
prediabetes. 
 Health behavior theories consist of key theoretical constructs that influence behavior and 
provide a framework for intervention. The constructs may work independently, concurrently, or 
in multiple layers and are applied at multiple points along a spectrum of behavior change from 
unawareness through behavior maintenance. Theories often share similar constructs although 
they are assumed to influence behaviors in different ways depending on when they are applied, 
therefore it is important to consider how theory-based curriculum may influence behavior change 
outcomes. Program planners often combine multiple theoretical frameworks to understand health 
behaviors that result in lack of engagement, guide development of programs, and implement 
curriculum to reinforce behavior change and maintenance (DiClemente et al., 2013; Rimer, et al., 





Theory of Planned Behavior, the Health Belief Model, Transtheoretical Model of Change, Social 
Cognitive Theory, and Diffusion of Innovation Theory.  
Theory of Reasoned Action and Theory of Planned Behavior 
 Theoretical models like the Theory of Reasoned Action (TRA) and the Theory of 
Planned Behavior (TPB) are based on concepts of value expectancy. Individuals form decisions 
related to health behavior change based on their perception and measure it in terms of the benefit 
versus the cost. A person’s perception of the benefit—what they will achieve by making 
behavior change— is measured against a perception of the effort they expect to make towards 
that change. These costs (efforts) may be measured by physical, social, emotional, or financial 
investment. The benefits may be directly related to health improvement, but they are often 
perceived in terms of physical ability or fitness, appearance and weight loss, or increased 
adoption of desired social norms such as participation in recreational sports and physical 
activities (Ajzen & Fishbein, 1980; DiClemente et al., 2013; Rimer, et al., 2005). 
 TRA, developed by Ajzen and Fishbein (1980), assumes that a person’s health behavior 
belief and their social influences are factors that shape their behavioral intent. The endpoint of 
the theory is an intention to perform a particular behavior and the next action will be the desired 
behavior. TRA definition of behavioral intention includes a timeframe for the behavior to be 
performed, an exact description of the action of the behavior, the outcome that is desired from 
the behavior, and the context of the behavior. Behavioral intention is mediated by attitude which 
is shaped by individual beliefs and evaluation of outcomes related to the behavior. Subjective 
norms also impact intent as they are formed in part by a person’s motivation to comply because 
of their perception of what people important to them would think about the behavior (Ajzen & 





 Ajzen (1988) expanded on the theoretical base of TRA to create the TPB model by 
adding a construct of perceived behavioral control. TBP assumes that perception of favorability 
towards a behavior, along with subject norms that support it, will influence the likelihood that a 
person will perceive control over the behavior. This perception is influenced by a number of 
external factors that may serve to either facilitate or inhibit the behavior. The factors that 
influence perception are not actualized but are part of evaluation of the value and benefit of 
behavior change and they may influence perception without cognitive thought (Ajzen, 1988; 
DiClemente et al., 2013).  
Theory of Planned Behavior and Current Study. Application of TPB to this research 
could align the mode of prediabetes diagnosis as one of the factors that influence attitude, subject 
norms, and perceived behavior control toward the behavioral intention to enroll in the DPP. 
Other factors that may influence behavioral intent include individual interpretation of 
promotional messaging, social interactions with people in the program, and their previous 
experiences or knowledge about prediabetes. Since the constructs of TPB applies to the intent to 
perform the behavior, the curriculum of the program would build on the factors that influenced 
their intention to participate, and could therefore lead to favorable outcomes from the program.    
 As discussed in the opening paragraph of this section, if a person receives a clinical 
diagnosis of prediabetes, their attitude toward behaviors, subject norm, and perceived control 
constructs could be influenced in part by the provider who provided the diagnosis. If the provider 
shares information about the program in a positive way, the patient may have a more favorable 
attitude toward the behavior expected from the program. The provider attitude may also 
influence the patient’s perception of normative behavior following a diagnosis of prediabetes if 





on their personal understanding of the elements of the DPP along with the knowledge and 
attitude of the medical provider towards the program (Mainous et al., 2016; Nhim, et al., 2018).  
 If a person completes a self-assessment for risk test as a prerequisite to participation in 
the DPP, they may be moving toward the TRA definition of behavioral intention as they consider 
the behavior timeframe, the behavior action, and desired outcome of the behavior.  They may 
already have a positive attitude towards the new behavior and perception of their behavioral 
control. If they attended the orientation session, their subject norm will likely be influenced by 
motivation to comply with the invitation to enroll and also by those in attendance who support a 
normative belief and positive attitude towards the behavior.  
Health Belief Model 
 Perception of threat and fear appeal theories build on the construct of value expectancy 
by adding perceptions that relate to threat or fear about the probability and severity of negative 
health outcomes. The Health Belief Model (HBM), developed by Rosenstock (1974), has been 
widely used in public health campaigns to motivate individuals toward behavior change 
(DiClemente et al., 2013; Rimer, et al., 2005). The Health Belief Model primary constructs are 
perceived susceptibility and severity, and perceived gain (benefit) from the behavior. These 
perceptions are influenced by personal moderators such as age, socioeconomic status, and 
knowledge about the health threat, as well as cues to action from events, or interventions that 
relate to the threat. An updated version of the model includes self-efficacy as an independent 
variable for health-related behavioral interventions because most people will not move toward 
new behavior unless they feel confident that they are capable of performing the behavior 





their perception of the severity of, and susceptibility to, the health problem (threat), and 
perception of gain from behavior change (DiClemente et al., 2013; Glanz & Bishop, 2010).  
 Health Belief Model and Current Study. Application of HBM to this research 
considers how the two different types of prediabetes diagnosis may impact individual 
perceptions of susceptibility and severity of disease. A person’s perception and likelihood of 
action will also influence their overall perceived threat of disease and therefore factor in the 
likelihood of taking preventative action by participating in the DPP. Individuals with either 
diagnosis will receive cues to action from promotional messaging and social interactions, as well 
as draw on prior knowledge to shape their perception. Their perceived threat of diabetes may be 
limited by lack of knowledge of the disease or enhanced by information regarding the finality of 
prediabetes progression towards diabetes. Reinforcement of behaviors that reduce risk will have 
a positive impact on their self-efficacy and influence the likelihood that they will take 
preventative action.  
 If the person has clinical diagnosis of prediabetes, their perception may be influenced by 
the provider who gave the diagnosis. Patients may experience increased perception of 
susceptibility and severity of disease due to the tangible element of a clinical test and knowledge 
from a medical professional. Personal assessment of disease risk may vary among educational 
levels and cause misunderstanding or communication barriers between patients and medical 
professionals regarding the risk factors and health threats associated with prediabetes and 
diabetes.  
 If a person completes a self-assessment for risk test as a prerequisite to participation in 
the DPP, they may already have a perception of their susceptibility and the severity of disease, as 





orientation session, their perception of gain from behavior change will likely be influenced by 
the testimonial of prior participants and the availability of information to assess risk.  
Transtheoretical Model of Change 
 The Transtheoretical Model of Change (TMC), developed by Prochaska & DiClemente 
(1983) has been used to facilitate motive for behavior change in a variety of health promotions 
(DiClemente et al., 2013; Glanz & Bishop, 2010; Rimer, et al., 2005). The TMC states that 
willingness to engage in a lifestyle change or behavior modification program occurs in stages of 
pre-contemplation, contemplation, preparation, action, and maintenance. Individuals may stop or 
step back at a particular stage rather than proceed sequentially towards a new health behavior. 
The processes of change are techniques or interventions that effectively enhance or promote 
movement to the next stage. Early stages of pre-contemplation to contemplation are reliant on 
awareness processes to affect change like consciousness-raising, or reevaluation. Other processes 
that are particularly effective at the contemplation stage include decisional balance - how a 
person evaluates and decides whether to adopt change - and self-efficacy. The TMC framework 
conceptualizes self-efficacy as both confidence and temptation, thus a person who has high 
confidence in their ability to resist temptation is considered to have resilient self-efficacy 
(DiClemente et al., 2013; Glanz & Bishop, 2010). 
 Transtheoretical Model of Change and Current Study. Application of TMC theory to 
this research could align mode of prediabetes diagnosis as factors that influence a process of 
change specific to stage levels and/or to the techniques prescribed for each process. The DPP 
program curriculum may support stage movement through self-efficacy as the participant gains 
new confidence in the program. A prediabetes diagnosis, regardless of mode—clinical or self-





external factors. In addition, cues to action from promotional messaging, social interactions, and 
prior knowledge could affect the decisional balance to adopt change. 
 If the person has clinical diagnosis of prediabetes, their perception of self-efficacy could 
be dependent on their understanding of the elements of the DPP at that time of the diagnosis as 
well as the knowledge and attitude of the medical provider towards the program. The 
information shared by the provider may not move the patient toward adoption of new behavior 
because it does not support the process needed for the patient’s current stage of change. Or, they 
may have experienced fear about the serious side effects associated with diabetes, then felt relief 
when they learned that DPP is available as effective prevention. This process of dramatic relief 
can be influential in moving a person from contemplation stage to preparation stage for new 
behavior. 
 If an individual completes a self-assessment for risk test as a prerequisite to participation, 
they may be in the contemplation of new behavior stage and the self-assessment may provide 
new information that informs their decisional balance and moves them into preparation stage.  
Or, they may already be in a preparation stage, with intention to adopt new behavior in the 
immediate future. In order to move to the next stage— action— they may require new skills and 
resources which could be learned as they go through the DPP curriculum. 
Social Cognitive Theory  
 Program planners may use a multilevel intervention strategy that includes messaging 
aimed at the population level in order to motivate the practice of positive health behaviors, or 
influence perceptions that will move people away from negative behaviors. The Social Cognitive 
Theory (SCT) developed by Bandura (1986) suggests that behavior is learned by observation and 





outcome from the behavior (Bandura,1986). This reciprocal relationship between an individual, 
their behavior, and their environment influences motivation and ability to adopt new behaviors. 
The key constructs of SCT are knowledge, perceived self-efficacy, outcome expectations, goal 
formation, and sociostructural factors. (DiClemente et al, 2013: Glanz & Bishop, 2010).  
 Social Cognitive Theory and Current Study. Application of SCT to this research is 
challenging as the constructs that influenced participation in DPP as a result of the prediabetes 
diagnosis will in turn influence new behavior expectations and the environment of the other 
participants in the DPP group. The prediabetes diagnosis regardless of mode—clinical or self-
test—is likely influenced by the sociostructural factors in the individual’s environment. If their 
environment and social interactions include people who model diabetes prevention behaviors 
(and have experienced expected outcomes from DPP) their behavior actions may be influenced 
by the collective self-efficacy in their environment.  
 If a person receives a clinical diagnosis of prediabetes they may not have any awareness 
of expected prevention-related behaviors or have opportunity to become knowledgeable about 
behaviors. SCT is like other theoretical applications to this research, in that individual 
perceptions and attitudes related to the expected outcomes can be influenced by the provider who 
provided the diagnosis. The patient’s perception of self-efficacy and ability to set goals related to 
behavior change could be influenced by the medical provider’s attitude and knowledge of DPP. 
 If an individual completes a self-assessment for risk test as a prerequisite to participation 
in DPP the person may already know about the program and an expectation of outcomes that 
could be obtained through participation. They may also have a greater prevention self-efficacy; 






Diffusion of Innovation Theory 
 Diffusion of Innovation Theory (DIT) is a social participatory model developed by 
Everett Rogers (2014) comprised of four primary concepts of innovation, communication, social, 
and time, that explain the way novel ideas (innovation) diffuse into social practices within a 
population to create new behavioral norms. Innovation is defined as an idea, practice, or concept 
that is perceived as new or novel to a population. The premise is that societal modeling of new 
behaviors will promote increased adoption of those behaviors. Like other stages of change 
models, individuals move through levels before the behavior becomes diffused: awareness, 
decision to adopt or reject innovation, initial exploration, and continued use or practice of the 
behavior. Individuals will consider factors like the relative advantage of the behavior, 
compatibility with their values and experience, whether there is opportunity to try the behavior 
without commitment, ability to discontinue the behavior, and whether the results are tangible 
prior to adoption of the behavior. As individuals begin adoption, they may consider the 
complexity of new behavior and the time commitment. Factors of commitment, modifiability, 
and observability of the results are usually considered after the innovation has been adopted 
(DiClemente et al, 2013; Rimer et al., 2005; Rogers, 2014). 
 Public health application has typically focused on using the DIT framework to facilitate 
adoption of preventative health behavior in specific population groups. Successful adoption of 
HIV/AIDS prevention behavior in San Francisco during the 1980’s AIDS epidemic has been 
attributed to use of interventions based on innovation theory (Bertrand, 2004). Similarly, a 
smoking cessation program modeled on innovation used multiple communication channels to 
increase awareness and positioned primary care physicians as influencers to change the 





 Diffusion of Innovation and Current Study. Application of DIT to this research 
considers how the two types of prediabetes diagnosis may work as predictors to adopting an 
innovation - participation in the DPP.  
 If a person has received a clinical diagnosis of prediabetes, it can be assumed that they 
are either unaware of the DPP, or at a stage of awareness about the program through 
communication. Research shows successful outcomes from positioning primary care physicians 
as influencers to change normative behaviors and attitudes towards behavior change (McManus, 
2013). Their ability to adopt the expected behavior may also be dependent on their interpretation 
of the complexity of the program and the time commitment.  
 If an individual completes a self-assessment for risk test as a prerequisite to participation 
in DPP they may be at the decision to adopt or reject innovation stage, or the initial exploration 
stage. They may be influenced by communication about the program within their social realm or 
by interaction with an innovator or early adopter. This person could benefit from the SCT-based 
DPP curriculum as facilitators affirm the advantage of the program (prevention of diabetes), the 
opportunity for tangible results (weight loss), and emphasize compatibility regarding how the 
program is designed to help everyone modify behaviors based on their lifestyle.  
The Current Study 
 The research aim of this study was to explore the association between mode of 
prediabetes diagnosis—clinical blood test or self-risk assessment—on measured DPP outcomes 
of attendance, physical activity minutes, percentage of weight loss, and combined goal 
achievement of all three measures. 
A number of common themes and assumptions were identified prior to the application of 





these outcomes. The assumed scenarios could indicate that the individual who completes a self-
assessment for risk test is at a more advanced stage of readiness for change than the person who 
receives a clinical diagnosis. Research indicates that early success with outcomes of weight loss 
and physical activity are a predictor for retention in the DPP and increased outcomes are 
associated with how long the individual is in the program. (Cannon et al., 2020; Ely et al., 2017; 
Jeffers et al., 2019). Therefore, they may be more likely to implement the behavioral 
modifications promoted in the DPP curriculum and be more receptive to the influence of 
elements of SCT curriculum in the DPP. This movement towards behavior change at the 
beginning of the program could influence the likelihood of early success and retention in the 
program. Evidence shows increased positive outcomes associated with how long the individual is 
in the program (Ely et al., 2017; Jeffers et al., 2019). 
 The first hypothesis proposes that participants who use a self-risk assessment to 
determine their diabetes risk will attend a greater median number of sessions than participants 
with clinical diagnosis of prediabetes. The second hypothesis states that participants who use a 
self-risk assessment will also have greater median weekly physical activity minutes as of session 
16 than those with clinical diagnoses. A third hypothesis states that participants use a self-risk 
assessment to determine diabetes risk have greater median percentage of weight loss than those 
with clinical diagnosis of prediabetes. The final hypothesis combines the goal outcomes of the 
program and claims that the number of participants who use self-assessment to determine 
diabetes risk and who achieve goal completion measures for attendance, physical activity, and 
percentage of weight loss is greater than participants with a clinical diagnosis of prediabetes who 






 CHAPTER III  
RESEARCH METHODOLOGY  
Study Design 
 This research study was a secondary data analysis utilizing a quantitative non-
experimental, cross-sectional design to investigate association between method of diagnosis of 
prediabetes—clinical blood test or self-risk assessment—and DPP outcomes.  
Procedures 
 This research used archival data from adults enrolled in a Diabetes Prevention Program 
(DPP) from 2017 to 2020 at Virginia Mason Memorial in Yakima Washington. Participants were 
eligible to enroll upon attendance of an orientation session and completion of required intake 
document. Variable information includes participant enrollment source, payer type, participant’s 
age, ethnicity, sex, height, education attainment, and prediabetes determination category. The 
prediabetes categories are clinical test, previous GDM, or self-risk assessment. Measures for 
clinical blood tests are either FG of 100 to 125 mg/dl, OGTT of 140 to 199 mg/dl, or A1c 
measure of 5.7% to 6.4%. Self-risk assessment is a positive screening for prediabetes risk using 
the ADA/CDC Prediabetes Risk Test (Figure 1).  
Program facilitators weighed participants before each session and recorded weight 
measures starting week 1 and participant-reported measures of physical activity (PA) minutes 
starting week 6. Data were entered into a secure reporting system by the facilitator or DPP 
coordinator, and the de-identified data were submitted bi-yearly to the CDC per agreement as a 
CDC-recognized organization. Participants were included in this study if they attended at least 
one DPP session delivered by VMM and data was collected for the outcomes of PA and weight 





enrollment data (2020) from 2017 to 2020; however, a number of participant files could not be 
retrieved and the number was reduced to 865 for analysis. An additional 72 records were 
removed due to duplication, or abnormalities in the data that could not be resolved. As shown in 
Figure 2, the final sample used for analysis was 793 participants, and 46.7% (n = 370) of 
participants qualify for DPP by clinical test or GDM, and 53.3% (n = 423) completed self-test.  
 
Sample Population 
 The demographic profile of study participants (N = 793) shown in Table 1, was 25% male 
(n = 201, 75% female (n = 592), aged 18 to 94 (𝑥 60, ?̃? 63). The racial and ethnic identity 
distribution was 83.6% White (n = 663), 14.8% Hispanic or Latino (n = 117), 1.5% American 
Indian or Alaska Native (n = 12), and 0.1% Other racial/ethnic identity which includes: Asian, 
Black, or African American, and Native Hawaiian or Other Pacific Islander. Group 1 (n = 370) 







Assessed for inclusion in study research 
(N = 865)
Excluded due to data errors 
and duplication (n = 72)
Analyzed (N = 793)
Group 1: Clinical Test              
(n = 370)






or previously diagnosed GDM. The Group included 37% male (n = 137), 63% female (n = 233), 
aged 18 to 84 (𝑥 59, ?̃? 61). The racial and ethnic identity distribution was 82.4% White, 16.2% 
Hispanic or Latino, 1.4% American Indian or Alaska Native. Group 2 (n = 423), includes 
participants who had a positive screening for prediabetes risk using the ADA/CDC Prediabetes 
Risk Test (Figure 1). Group 2 was 15% male (n = 64), 85% female (n = 359), aged 27 to 94 (𝑥 
62, ?̃? 64). The racial and ethnic identity distribution was 84.6% White, 13.5% Hispanic or 
Latino, 1.5% American Indian or Alaska Native. 
Table 1 
      
 
      
Demographic Profile of Study Participants       
Variables 
Group 1 Clinical 
Test (n = 370) 
Group 2 Self-Test         
(n = 423) 
Full Study Sample     
(N = 793) 
  n % n % n % 
Gender       
Male 137 37 64 15 201 25 
Female 233 63 359 85 592 75 
Age       
Mean 59  62  60  
Median 61  64  63  
Range 18-84  27-94  18-94  
Racial/Ethnic       
White 305 82.4 358 84.6 663 83.6 
Hispanic or Latino 60 16.2 57 13.5 117 14.8 
American Indian or Alaska 
Native 5 1.4 7 1.7 12 1.5 
Other racial/ethnic identity 2 0.05 1 0.02 1 0.4 
       
Note. Other racial/ethnic identity includes: Asian, Black, or African American, and Native Hawaiian 






Preparation of Data 
 This research used a password-protected Microsoft Excel worksheet for management and 
analysis of the de-identified data. Raw data was organized to allow for identification of 
abnormalities in the data and statistical analysis of variables. Outliers and presumed data errors 
were fact-checked and verified by the program coordinator before inclusion in this research. A 
standard protocol for estimating missing data for measures of PA and weight loss was 
implemented. If participants missed one session (>6 <17) mean PA minutes from the two closest 
measures were entered for that date (609 missing data records [weeks 7-16] used estimated data). 
Participants who missed 2> consecutive sessions were documented as zero for the missing dates. 
Mean WL data was used for participants who missed session 16 but attended sessions 15 and 17. 
There were 37 entries with estimated weight loss. 
Statistical Analysis 
 This research places the method of diagnosis for prediabetes, clinical test or self-test, as 
dichotomous independent variables and the median attendance, weekly PA, and WL% as 
dependent variables.  
 The independent variable (IV) was categorical with two Groups as shown in Figure 2. 
Group 1 (clinical test) includes participants who were eligible for the DPP based on laboratory 
blood tests within the past year, or previously diagnosed GDM. Group 2 (self-test) includes 
participants who had a positive screening for prediabetes risk using the ADA/CDC Prediabetes 
Risk Test (Figure 1).  
 Participants in both Groups were measured on dependent variable (DV) outcomes of 1) 
attendance, 2) PA, 3) percentage of weight loss (WL%), and 4) achievement of program goal 





sessions was measured as continuous interval data of the number attended (>1, <17). The DV for 
self-reported PA minutes per week was proposed as a categorical score based on continuous 
interval data of weekly PA minutes (>6, <17). 0= zero weekly PA minutes, 1= >0 to <59, 2= >60 
to <150, 3= ≥151. This was proposed to reduce the range of distribution in the data. However, 
the method was changed to measure PA minute as continuous interval median data when 
analysis revealed non-parametric data and similar results. In addition, this measure aligns with 
DPP program goal outcomes of 150 mean PA minutes per week. The weight loss DV was 
measured as continuous interval data using percentage of WL from the starting weight through 
the highest attended session (>1, <17). The goal completion outcomes DV was based on the 
NDPP recommended outcomes to achieve maximum diabetes risk reduction: ≥16 weeks of 
session attendance, ≥150 mean weekly PA minutes, and >5% weight loss. The goal completion 
DV was measured using a discrete-binary variable (>16). 0= attendance <16, PA <150, and 
WL% <5%. 1= attendance ≥16, PA ≥150, and WL% ≥5%.  
 The data analysis ToolPak in Microsoft Excel (2016) was used to perform data analysis 
unless otherwise indicated. Dependent variable mean and median were assessed visually using 
Box and Whisker graphs, and statistical analysis used Skewness and Kurtosis measures to 
calculate departure from normality, and Kolmogorov-Smirnov (KS) calculator (Smirnov, 1948; 
AAT Bioquest, 2021) to determine variance (normalcy) of data. The variables for attendance, PA 
minutes, and WL% were asymmetrical (non-parametric) thus the Wilcoxon Mann-Whitney U test 
(Mann, & Whitney, 1947; Social Science Statistics, n.d.) was used to compare median outcomes. 
The alpha significance level of 0.5 was used for the 2-tailed hypothesis analysis. A z test for 
proportions was used for analysis for the binary variable for goal completion (Social Science 





Table 2    
 
   
Study Measures and Statistical Analysis   
 
   
Dependent Variable  Statistical analysis 
 





Continuous interval data 
(<1,<17) 
Visual analysis:              
Box and Whiskers 
graph  
Statistical analysis:   
Skewness and Kurtosis 




Whitney U Test = 0.5 
alpha level 
Hypothesis 2:          
Physical Activity 
Minutes 
Continuous interval data 
(<6,<17) 
Hypothesis 3:       
Percent of weight 
loss 
Continuous interval data 
(<1,<17) 
Hypothesis 4:            
Goal outcome 
attainment 
Discrete binary variable:   
0= Attendance <16, PA 
<150, and WL% <5.%.   
1= Attendance ≥16, PA 
≥150, and WL% ≥5.%.  
n/a z test for proportions 
Note. The DV for participant self-reported PA minutes was proposed for research as a categorical 
score based on continuous interval data of weekly PA minutes reduce the range of normalcy. The 
method of analysis was changed to measure PA minute as continuous interval median data when 
analysis revealed non-parametric data and similar statistical results. In addition, this measure aligns 








 The research aim of this study was to explore the association between mode of 
prediabetes diagnosis—clinical blood test or self-risk assessment—on measured DPP outcomes 
of attendance, physical activity minutes, percentage of weight loss, and combined goal 
achievement of all three measures.  
 Hypothesis 1:  Participants with DPP eligibility using self-assessment to determine 
diabetes risk attend a greater median number of sessions (>1, <17) than participants with clinical 
diagnosis of prediabetes. μ Self-test > μ Clinical  
 The evaluation of attendance measures (Table 3) revealed that all participants achieved 
median attendance of 13 sessions; however, the calculation for Group 1 (clinical test) showed a 
higher average rank mean (416) than Group 2 (self-test) rank mean of 380. This indicates 
increased attendance values for those with a clinical diagnosis as a whole. The results were 
significant (p < .0251) but did not support the directional hypothesis. Participants who had a 
clinical diagnosis of prediabetes achieved increased outcomes of attendance in the DPP. 
 Hypothesis 2: Participants with DPP eligibility using self-assessment to determine 
diabetes risk have greater median weekly physical activity minutes (>6, <17) than those with 
clinical diagnosis of prediabetes. μ Self-test > μ Clinical   
 Group 1 (clinical diagnosis) achieved higher median self-reported minutes of physical 
activity (?̃? =110, mean rank 414) compared with Group 2 who completed the self-risk test  
(?̃? =90, mean rank 382). The results shown in Table 3 were significant (p < .049) and did not 
support the directional hypothesis. Participants who had a clinical diagnosis of prediabetes 





 Hypothesis 3: Participants with DPP eligibility using self-assessment to determine 
diabetes risk have greater median percentage of weight loss (>1, <17) than those with clinical 
diagnosis of prediabetes. μ Self-test > μ Clinical 
 Table 3 shows no significant differences in the measures for percentage of weight loss 
between the clinical diagnosis Group 1 (?̃?  =.051, mean rank 402), and the self-risk test Group 2 
(?̃?  =.048, mean rank 393). The results failed to reject the null hypothesis (p < .610). 
 Hypothesis 4:  The number of participants with DPP eligibility using self-assessment to 
determine diabetes risk who achieve goal completion outcomes of attendance ≥16 weeks, median 
weekly physical activity ≥ 150 minutes, and percentage of weight loss ≥ 5% is greater than 
participants with a clinical diagnosis of prediabetes who achieve goal completion. μ Self-test > μ 
Clinical 
  The measures of goal completion in Table 4 show less than 5% (n = 38, 4.79%) of the 
study participants (N = 793) completed the DPP goal completion outcomes of 16 weeks of 
attendance, 150 median minutes of physical activity, and 5% weight loss. The largest proportion 
(n =24, p̂ =.0649) were participants from Group 1 versus participants from Group 2 (n =14, p̂ 
=.0331). This was a significant result (p < .018) that rejected the null hypothesis that the sample 
portions are equal and supports that more participants with a clinical diagnosis of prediabetes 
achieved all of the goal outcomes of attendance in the DPP.  














        
Statistical Results for Measures of Attendance, Physical Activity, and % of Weight Loss  
        
Statistical Measure Attendance 
Physical Activity 
Minutes 
% of Weight Loss  
              
  
Group 1:  
Clinical 

















Median 13 13 110 90 0.051 0.048  
Range 15 15 998 997 0.210 0.238  
Mean of Ranks 416 380 414 382 402 393  
Sample Mean of 
Ranks 
397 397 397  
p-value 0.025 0.049 0.610  
U-value 71062 71905 76608  
Z -score -2.23506 -1.97294 -0.51165  
r value 0.99 0.91 0.99  
               
 Result is significant  Result is significant  
Result is NOT 
significant   









Table 4   
   
Statistical Results for Measures of Goal Outcome Achievement 




  Group 1:  Clinical Test Group 2: Self Risk Test 
Proportion 0.0649 0.0331 
CL (95%) 0.0438-0.0859 0.0188 - 0.0474 
Z -value 2.0894 
p value 0.018 







 Diabetes is an irreversible, chronic disease that is estimated to affect 1 in 6 adults in the 
United States by the year 2060. Diabetes will continue to have a negative impact on health, 
quality of life, and the economy unless the incidence rate is decreased. There is no known cure 
for diabetes, so prevention is the preferred medical action at the prediabetes stage. Clinical trials 
support that behavior modification techniques resulting in weight loss and increased physical 
activity are effective in preventing or delaying the development of diabetes. The DPP is a 
valuable program for behavioral change, but many participants struggle to adopt lifestyle 
modifications necessary to achieve the outcomes of the class. Many of the barriers to behavioral 
change are factors that could be influenced by increased awareness, motivation, perception of 
individual ability and likelihood of success, and attitudes of the people who hold positions of 
influence in a person’s life.  
 As identified in the introduction, despite general awareness of the health threat associated 
with diabetes, and evidence to support effective intervention at the prediabetes stage, many 
individuals with prediabetes do not make or sustain modifications to behavior that will lower 
their risk. In order to minimize incidence and prevalence of type 2 diabetes, it was critical to 
assess possible factors that influence individual motivation to engage in risk reduction behaviors. 
This research focused on a moment in time when the threat of developing diabetes became a 
reality for many people regardless of their mode of prediabetes diagnosis. Since the data 
available for analysis was gathered from a diabetes prevention program, it could be assumed that 
the clinical diagnosis or confirmation of risk based on the self-test was a driving force for 





relationship. Specifically, whether one method of prediabetes diagnosis is associated with greater 
outcomes from the program, measured by attendance, physical activity minutes, and weight loss. 
 The main study findings were that the group of people who had a clinical diagnosis of 
prediabetes had greater measures of attendance, physical activity, and measures of goal 
completion than the group of people who completed a self-risk assessment to determine diabetes 
risk. The study measures for percentage of weight loss indicated that there was no significant 
difference between the Groups.  
 The development of the directional hypothesis for this research was based on study of 
theoretical frameworks that influence behavior change and how they could be applied to 
individuals based on their mode of diagnosis. As shared at the beginning of that section, several 
assumptions were used to rationalize the possible behavior of individuals before participation in 
DPP.  
 It was presumed that when a person receives a clinical diagnosis of prediabetes that they 
are unaware of their condition, and they will be greatly influenced by the health professional that 
delivers the diagnosis. Their initial perceptions may be influenced by the attitude, perceptions, 
and knowledge of the provider as it relates to diabetes risk. It was also assumed that they were in 
a state of receiving information rather than actively seeking a diagnosis or confirmation of health 
threat. Because of the demographic makeup of individuals in the program, it was assumed that 
they have a relationship with their provider and would likely have contact with them at some 
point during the program.  
 Because enrollment in the DPP program requires either a clinical diagnosis of prediabetes 
or a self-assessment test that confirms risk of diabetes, it was assumed that intent to participate in 





extensively in the Yakima Valley in conjunction with messaging about diabetes risk and Virginia 
Mason Memorial community health events. Attendees at the DPP informational/orientation 
meeting are given an opportunity to take the assessment if they want to enrollment in the class. If 
an individual completes a risk test as a prerequisite to participation in DPP, it could be presumed 
that they were aware of the prevention program and have a perception of the value of 
participation in the program. It could also be assumed that they are in a state of seeking 
information. If they completed the test after attending orientation, it could be assumed that it was 
their decision to attend the orientation, perhaps with the intention to enroll, prior to receiving 
information about the program. It can be expected that the individual used critical thinking and 
honest assessment when they completed the risk test and in a state of prediabetes. 
 Research indicates that early success with outcomes of weight loss and physical activity 
are a predictor for retention in the DPP and increased outcomes are associated with how long the 
individual is in the program. (Cannon et al., 2020; Ely et al., 2017; Jeffers et al., 2019). The 
assumed scenarios could indicate that the individual who completes a self-assessment for risk 
test is at a more advanced stage of readiness for change than the person who receives a clinical 
diagnosis. If they attended the orientation session, their perception of gain from behavior change 
will likely be influenced by the testimonial of prior participants and the information shared. They 
may be more readily influenced by positive communication about the program within their social 
circle. This person could benefit from the SCT-based DPP curriculum as facilitators affirm the 
advantage of the program (prevention of diabetes), the opportunity for tangible results (weight 
loss), and emphasize compatibility regarding how the program is designed to help individuals 
modify behaviors based on their lifestyle. Therefore, the premise of the directional hypothesis 





behavioral modifications at the beginning of the program, which would influence the likelihood 
of early success as well as retention, which would lead to increased outcomes from the program.  
 This choice of hypothesis direction was based on a variety of assumptions about both of 
the methods of diagnosis. Many of the presumed scenarios for those who receive a clinical 
diagnosis were also considered influential for positive behavior change in DPP.  
 For example, providers who routinely refer to the diabetes prevention program have 
access to health education materials and resources developed specifically for promotion of DPP. 
These resources can be beneficial in influencing the perception of favorable attitudes and 
expectations related to behavioral change and move patients towards intent to engage in health 
prevention behavior as described in the literature review on Theory of Planned Behavior.  The 
patient/provider relationship may have the most influence within the framework of the Health 
Belief Model. Patients may experience increased perception of susceptibility and severity of 
disease due to the tangible element of a clinical test and knowledge from a medical professional. 
Ethical Considerations and Limitations 
 Ethical considerations for this study are minimal due to the observational nature of the 
data. A letter of cooperation for data sharing was obtained from VMM, and exempt status was 
granted from Human Subjects Research Council at Central Washington University.  
 Threats to validity may include data collection errors and facilitator bias. Data collection 
errors related to weight loss may occur during the collection and preliminary documentation of 
the measures taken at each session. Participants are requested to wear similar clothing each week 
and remove their shoes for weighing, but the recommendation is not enforced. The facilitator 
may misread the weight, or incorrectly document the data in the tracking sheet at the time, or 





facilitator or the program coordinator. Weekly PA minutes are self-reported by participants 
without evidence of intensity or duration and the same documentation errors may occur as with 
the WL measures. There may be inconsistent methods for rounding fractional weight 
measurements and weekly PA minutes up or down, and there may be unconscious bias to reward 
or confirm expectations of the participants with higher weight loss results, or increased PA.  
Participants may not attend every class, resulting in missing data for some weeks. These 
threats were addressed by using Scatterplot and Standard deviation tests to determine outliers. 
Data was cross-referenced and verified by the diabetes program coordinator at Virginia Mason 
Memorial. A protocol was developed for estimating data that was missing from participant 
records and the occurrence was included in the study results.  
 These threats to validity may be mitigated through increased oversight during the weight 
data collection such as two-person validation at the time of collection. Other process 
improvement steps could include immediate data entry into the VMM data program, or digital 
scales networked to a data system to automatically record weight into a participant file. 
Participant PA minutes could be measured using approved activity tracking devices and 
documentation uploaded to a data system or printed out for manual data entry. 
 The study sample is not appropriate for generalization because it does not fully represent 
the racial and ethnic profile of the community (see Table 2). In addition, the study participants 
may be more likely to have a primary care provider, or medical home, because the program is 
coordinated by a large health care organization affiliated with multiple family practice clinics in 
Yakima Valley. The majority of physicians who refer patients to DPP are associated with this 
healthcare system and have increased awareness of the program due to direct outreach and access 





 The assumptions used in the theoretical analysis are limited to the sample and scope of 
this study and do not reflect the needs of historically underrepresented populations or those 
negatively affected by social determinates of health.  
Implications for Further Research 
 The implications drawn from this study may provide valuable insight into the ways that 
health behavior theory can be used to understand an individual’s possible reaction to a diagnosis 
of disease. Further research is necessary to explore the assumptions that were considered to 
understand ways that method of diagnosis may influence outcomes attained through DPP. The 
assumptions may be valid; however, due to the historical nature of the data used in this study 
they cannot be tested with reliability. Recommendations for further research involve robust 
multi-point data collection to better understand and define the mechanisms that influence 
individuals at the point of diagnosis by clinical testing, including identification of factors may 
that prevent or deter those persons from participation. 
There is opportunity for increased understanding of the factors that motivate people to 
complete the self-risk test. Supplemental questions could identify if the assumption used in this 
study—desire to attend DPP—is the most salient factor, or whether there are barriers to clinical 
access and referral to the program. If participants identify that weight loss was the motivation, 
(rather than diabetes prevention) it may indicate a need for effective WL programming in the 
community.  
Further research could also expand the statistical analysis of the data to measure 
correlations between the participant variables, their mode of diagnosis, and the outcomes of the 
program. Additional analysis could also reveal if there are patterns of retention based on goal 






  The National Diabetes Prevention Program is an effective way to decrease risk and 
incidence of diabetes. Although the results of this study reflect the impact of secondary 
prevention, they could be used to move intervention upstream to increase primary screening 
procedures and referral with medical professionals. Practical application of the relative 
association between clinical blood test and goal outcomes will inform health educators and 
providers regarding potential for increased benefit from participation in DPP. Programmers may 
see value in expansion of screening and streamlined referral methods to ensure access to clinical 
diagnosis. Providers may explore methods of clinical referral outside of the primary care setting 
such as dental or ophthalmology prescreening.  
The association could also guide communication and marketing efforts to promote DPP 
through patient interaction and support creation of educational materials for clinic use. 
Additional resources may be put into position to aid in the transition from diagnosis to DPP 
attendance. The results may influence physician attitudes regarding patient self-assessment and 
provide new opportunity to analyze positive outcomes of LSM programming on population 
health, regardless of prediabetes or diabetes risk status. In addition, the association may influence 
coverage options for insurance and workplace health and wellness programs, as well as support 
and funding for DPP on the County, State, and Federal policy levels. 
Many health care organizations are severely impacted by medical care and associated 
costs directed towards tertiary treatment of diabetes incidence. This has the potential to limit 
their ability to offer prevention programming that will decrease risk of developing diabetes. 
Therefore, strategies to increase effectiveness in diabetes prevention programming are of critical 
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Appendix A - Tables 
Table 1 
      
 
      
Demographic Profile of Study Participants       
Variables 
Group 1 Clinical 
Test (n = 370) 
Group 2 Self-Test         
(n = 423) 
Full Study Sample     
(N = 793) 
  n % n % n % 
Gender       
Male 137 37 64 15 201 25 
Female 233 63 359 85 592 75 
Age       
Mean 59  62  60  
Median 61  64  63  
Range 18-84  27-94  18-94  
Racial/Ethnic       
White 305 82.4 358 84.6 663 83.6 
Hispanic or Latino 60 16.2 57 13.5 117 14.8 
American Indian or Alaska 
Native 5 1.4 7 1.7 12 1.5 
Other racial/ethnic identity 2 0.05 1 0.02 1 0.4 
       
Note. Other racial/ethnic identity includes: Asian, Black, or African American, and Native Hawaiian 






Table 2    
 
   
Study Measures and Statistical Analysis   
 
   
Dependent Variable  Statistical analysis 
 





Continuous interval data 
(<1,<17) 
Visual analysis:              
Box and Whiskers 
graph  
Statistical analysis:   
Skewness and Kurtosis 




Whitney U Test = 0.5 
alpha level 
Hypothesis 2:          
Physical Activity 
Minutes 
Continuous interval data 
(<6,<17) 
Hypothesis 3:       
Percent of weight 
loss 
Continuous interval data 
(<1,<17) 
Hypothesis 4:            
Goal outcome 
attainment 
Discrete binary variable:   
0= Attendance <16, PA 
<150, and WL% <5.%.   
1= Attendance ≥16, PA 
≥150, and WL% ≥5.%.  
n/a z test for proportions 
Note. The DV for participant self-reported PA minutes was proposed for research as a categorical 
score based on continuous interval data of weekly PA minutes reduce the range of normalcy. The 
method of analysis was changed to measure PA minute as continuous interval median data when 
analysis revealed non-parametric data and similar statistical results. In addition, this measure aligns 







Table 3        
        
Statistical Results for Measures of Attendance, Physical Activity, and % of Weight Loss  
        
Statistical Measure Attendance 
Physical Activity 
Minutes 
% of Weight Loss  
              
  
Group 1:  
Clinical 

















Median 13 13 110 90 0.051 0.048  
Range 15 15 998 997 0.210 0.238  
Mean of Ranks 416 380 414 382 402 393  
Sample Mean of 
Ranks 
397 397 397  
p-value 0.025 0.049 0.610  
U-value 71062 71905 76608  
Z -score -2.23506 -1.97294 -0.51165  
r value 0.99 0.91 0.99  
               
 Result is significant  Result is significant  
Result is NOT 
significant   









Table 4   
   
Statistical Results for Measures of Goal Outcome Achievement 




  Group 1:  Clinical Test Group 2: Self Risk Test 
Proportion 0.0649 0.0331 
CL (95%) 0.0438-0.0859 0.0188 - 0.0474 
Z -value 2.0894 
p value 0.018 





Appendix B – Figures 
Figure 1  
ADA/CDC Prediabetes Risk Test 
 












Assessed for inclusion in study research 
(N = 865)
Excluded due to data errors 
and duplication (n = 72)
Analyzed (N = 793)
Group 1: Clinical Test              
(n = 370)






Appendix C - List of Acronyms 
A1c   Hemoglobin A1c 
ADA   American Diabetes Association 
BMI   Body mass index 
CDC   Centers for Disease Control and Prevention 
CI   Confidence interval 
DIT  Diffusion of Innovation Theory 
DPP   Diabetes prevention program 
DPRP   Diabetes Prevention Recognition Program 
FPG   Fasting plasma glucose 
GDM   Gestational diabetes mellitus 
HBM  Health Belief Model  
HHS   Health & Human Services 
LSM  Lifestyle Management 
MDPP  Medicare Diabetes Prevention Program  
NDPP   National Diabetes Prevention Program 
NHIS  National Health Interview Study 
NIDDK National Institute of Diabetes and Digestive and Kidney Diseases 
𝑥  Mean 
?̃?  Median 
OGTT  Oral glucose tolerance test 
PA  Physical Activity 
PCP  Primary Care Physician 
SCT  Social Cognitive Theory  
TMC  Transtheoretical Model of Change 
TPB  Theory of Planned Behavior  
TRA  Theory of Reasoned Action 
VMM  Virginia Mason Memorial 
WL%  Weight Loss Percentage 
 
